25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Jw Pharmac
Buy, Hold or Sell?

Let's analyze Jw Pharmac together

I guess you are interested in Jw Pharmac. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jw Pharmac. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Jw Pharmac

I send you an email if I find something interesting about Jw Pharmac.

1. Quick Overview

1.1. Quick analysis of Jw Pharmac (30 sec.)










1.2. What can you expect buying and holding a share of Jw Pharmac? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
85.0%

What is your share worth?

Current worth
₩12,332.14
Expected worth in 1 year
₩13,238.53
How sure are you?
72.5%

+ What do you gain per year?

Total Gains per Share
₩906.39
Return On Investment
3.4%

For what price can you sell your share?

Current Price per Share
₩27,000.00
Expected price per share
₩24,950 - ₩30,900
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Jw Pharmac (5 min.)




Live pricePrice per Share (EOD)
₩27,000.00

2.2. Growth of Jw Pharmac (5 min.)




Is Jw Pharmac growing?

Current yearPrevious yearGrowGrow %
How rich?$198.4m$161.5m$25.4m13.6%

How much money is Jw Pharmac making?

Current yearPrevious yearGrowGrow %
Making money$6.2m$8.9m-$2.7m-43.8%
Net Profit Margin4.6%7.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Jw Pharmac (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Jw Pharmac?

Welcome investor! Jw Pharmac's management wants to use your money to grow the business. In return you get a share of Jw Pharmac.

First you should know what it really means to hold a share of Jw Pharmac. And how you can make/lose money.

Speculation

The Price per Share of Jw Pharmac is ₩27,000. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jw Pharmac.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jw Pharmac, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩12,332.14. Based on the TTM, the Book Value Change Per Share is ₩226.60 per quarter. Based on the YOY, the Book Value Change Per Share is ₩768.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jw Pharmac.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.260.0%0.270.0%0.390.0%0.090.0%0.060.0%
Usd Book Value Change Per Share0.250.0%0.160.0%0.540.0%0.040.0%0.050.0%
Usd Dividend Per Share0.000.0%0.000.0%0.270.0%0.160.0%0.120.0%
Usd Total Gains Per Share0.250.0%0.160.0%0.810.0%0.210.0%0.180.0%
Usd Price Per Share21.18-24.06-14.56-20.63-25.18-
Price to Earnings Ratio20.42-6.35-9.77-15.21-40.98-
Price-to-Total Gains Ratio84.56-37.62-20.28--57.21--19.80-
Price to Book Ratio2.45-2.98-2.07-3.03-3.49-
Price-to-Total Gains Ratio84.56-37.62-20.28--57.21--19.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share18.9
Number of shares52
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.16
Usd Book Value Change Per Share0.160.04
Usd Total Gains Per Share0.160.21
Gains per Quarter (52 shares)8.2510.77
Gains per Year (52 shares)32.9943.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10332334933
206656681876
30998910227119
4013212213637162
5016515517046205
6019818820455248
7023122123864291
8026425427273334
9029728730582377
10033032033992420

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%10.02.00.083.3%13.07.00.065.0%26.011.03.065.0%31.011.04.067.4%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%12.08.00.060.0%23.017.00.057.5%28.018.00.060.9%
Dividend per Share1.00.03.025.0%9.00.03.075.0%15.00.05.075.0%34.00.06.085.0%38.00.08.082.6%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%14.06.00.070.0%29.011.00.072.5%34.012.00.073.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Jw Pharmac compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--357.732226.598+58%768.126-53%62.875+469%74.000+383%
Book Value Per Share--12332.13711621.979+6%10038.465+23%9816.877+26%10312.081+20%
Current Ratio--1.3421.284+5%1.138+18%1.286+4%1.070+25%
Debt To Asset Ratio--0.5730.594-4%0.641-11%0.630-9%0.612-6%
Debt To Equity Ratio--1.3421.472-9%1.719-22%1.700-21%1.592-16%
Dividend Per Share---0.000-100%383.337-100%233.089-100%176.535-100%
Eps--370.259387.818-5%553.909-33%128.394+188%84.555+338%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.925+8%
Market Cap620651700000.000-12%695360349750.000790069446871.500-12%478096330350.000+45%677590747587.762+3%841468112852.955-17%
Net Profit Margin--0.0490.046+7%0.071-30%0.012+329%0.010+386%
Operating Margin----0%0.080-100%0.027-100%0.025-100%
Operating Ratio--1.1741.340-12%1.200-2%1.408-17%1.269-7%
Pb Ratio2.189-12%2.4532.982-18%2.072+18%3.034-19%3.489-30%
Pe Ratio18.230-12%20.4256.349+222%9.770+109%15.208+34%40.982-50%
Price Per Share27000.000-12%30250.00034366.500-12%20793.975+45%29475.378+3%35978.195-16%
Price To Free Cash Flow Ratio---5.588-100%5.357-100%-2.1700%-3.3390%
Price To Total Gains Ratio75.476-12%84.56137.620+125%20.275+317%-57.208+168%-19.797+123%
Quick Ratio---0.563-100%0.710-100%0.711-100%0.869-100%
Return On Assets--0.0130.014-7%0.020-35%0.004+200%0.003+332%
Return On Equity--0.0300.031-3%0.053-43%0.011+184%0.007+311%
Total Gains Per Share--357.732226.598+58%1151.463-69%295.963+21%250.534+43%
Usd Book Value--198436208.600187024799.260+6%161563284.829+23%157973182.273+26%167447901.872+19%
Usd Book Value Change Per Share--0.2500.159+58%0.538-53%0.044+469%0.052+383%
Usd Book Value Per Share--8.6328.135+6%7.027+23%6.872+26%7.218+20%
Usd Dividend Per Share---0.000-100%0.268-100%0.163-100%0.124-100%
Usd Eps--0.2590.271-5%0.388-33%0.090+188%0.059+338%
Usd Free Cash Flow---14636837.758-100%5088618.901-100%7303366.700-100%5941823.015-100%
Usd Market Cap434456190.000-12%486752244.825553048612.810-12%334667431.245+45%474313523.311+3%589027678.997-17%
Usd Price Per Share18.900-12%21.17524.057-12%14.556+45%20.633+3%25.185-16%
Usd Profit--5957826.7006239218.930-5%8973611.826-34%2072377.524+187%1411825.551+322%
Usd Revenue--120593209.800129865815.193-7%126404526.812-5%111530593.654+8%98258401.584+23%
Usd Total Gains Per Share--0.2500.159+58%0.806-69%0.207+21%0.175+43%
 EOD+3 -4MRQTTM+16 -14YOY+12 -195Y+23 -710Y+23 -8

3.3 Fundamental Score

Let's check the fundamental score of Jw Pharmac based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1518.230
Price to Book Ratio (EOD)Between0-12.189
Net Profit Margin (MRQ)Greater than00.049
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.342
Debt to Asset Ratio (MRQ)Less than10.573
Debt to Equity Ratio (MRQ)Less than11.342
Return on Equity (MRQ)Greater than0.150.030
Return on Assets (MRQ)Greater than0.050.013
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Jw Pharmac based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.388
Ma 20Greater thanMa 5027,995.000
Ma 50Greater thanMa 10028,139.000
Ma 100Greater thanMa 20029,320.000
OpenGreater thanClose27,000.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Jw Pharmac

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.

Fundamental data was last updated by Penke on 2024-10-27 15:04:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Jw Pharmac earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Jw Pharmac to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 4.9% means that ₩0.05 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jw Pharmac:

  • The MRQ is 4.9%. The company is making a profit. +1
  • The TTM is 4.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.9%TTM4.6%+0.3%
TTM4.6%YOY7.1%-2.5%
TTM4.6%5Y1.2%+3.5%
5Y1.2%10Y1.0%+0.1%
4.3.1.2. Return on Assets

Shows how efficient Jw Pharmac is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jw Pharmac to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.3% Return on Assets means that Jw Pharmac generated ₩0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jw Pharmac:

  • The MRQ is 1.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.3%TTM1.4%-0.1%
TTM1.4%YOY2.0%-0.6%
TTM1.4%5Y0.4%+1.0%
5Y0.4%10Y0.3%+0.1%
4.3.1.3. Return on Equity

Shows how efficient Jw Pharmac is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jw Pharmac to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.0% Return on Equity means Jw Pharmac generated ₩0.03 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jw Pharmac:

  • The MRQ is 3.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.0%TTM3.1%-0.1%
TTM3.1%YOY5.3%-2.2%
TTM3.1%5Y1.1%+2.0%
5Y1.1%10Y0.7%+0.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Jw Pharmac.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Jw Pharmac is operating .

  • Measures how much profit Jw Pharmac makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jw Pharmac to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jw Pharmac:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY8.0%-8.0%
TTM-5Y2.7%-2.7%
5Y2.7%10Y2.5%+0.2%
4.3.2.2. Operating Ratio

Measures how efficient Jw Pharmac is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.17 means that the operating costs are ₩1.17 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Jw Pharmac:

  • The MRQ is 1.174. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.340. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.174TTM1.340-0.166
TTM1.340YOY1.200+0.140
TTM1.3405Y1.408-0.067
5Y1.40810Y1.269+0.138
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Jw Pharmac.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Jw Pharmac is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.34 means the company has ₩1.34 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Jw Pharmac:

  • The MRQ is 1.342. The company is just able to pay all its short-term debts.
  • The TTM is 1.284. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.342TTM1.284+0.058
TTM1.284YOY1.138+0.146
TTM1.2845Y1.286-0.003
5Y1.28610Y1.070+0.216
4.4.3.2. Quick Ratio

Measures if Jw Pharmac is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jw Pharmac to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jw Pharmac:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.563-0.563
TTM0.563YOY0.710-0.147
TTM0.5635Y0.711-0.148
5Y0.71110Y0.869-0.158
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Jw Pharmac.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Jw Pharmac assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jw Pharmac to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.57 means that Jw Pharmac assets are financed with 57.3% credit (debt) and the remaining percentage (100% - 57.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jw Pharmac:

  • The MRQ is 0.573. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.594. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.573TTM0.594-0.021
TTM0.594YOY0.641-0.047
TTM0.5945Y0.630-0.036
5Y0.63010Y0.612+0.018
4.5.4.2. Debt to Equity Ratio

Measures if Jw Pharmac is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jw Pharmac to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 134.2% means that company has ₩1.34 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jw Pharmac:

  • The MRQ is 1.342. The company is able to pay all its debts with equity. +1
  • The TTM is 1.472. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.342TTM1.472-0.130
TTM1.472YOY1.719-0.246
TTM1.4725Y1.700-0.228
5Y1.70010Y1.592+0.108
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Jw Pharmac generates.

  • Above 15 is considered overpriced but always compare Jw Pharmac to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 20.42 means the investor is paying ₩20.42 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jw Pharmac:

  • The EOD is 18.230. Based on the earnings, the company is fair priced.
  • The MRQ is 20.425. Based on the earnings, the company is fair priced.
  • The TTM is 6.349. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD18.230MRQ20.425-2.194
MRQ20.425TTM6.349+14.076
TTM6.349YOY9.770-3.421
TTM6.3495Y15.208-8.859
5Y15.20810Y40.982-25.774
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jw Pharmac:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.588-5.588
TTM5.588YOY5.357+0.231
TTM5.5885Y-2.170+7.758
5Y-2.17010Y-3.339+1.169
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Jw Pharmac is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.45 means the investor is paying ₩2.45 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Jw Pharmac:

  • The EOD is 2.189. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.453. Based on the equity, the company is underpriced. +1
  • The TTM is 2.982. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.189MRQ2.453-0.264
MRQ2.453TTM2.982-0.529
TTM2.982YOY2.072+0.909
TTM2.9825Y3.034-0.052
5Y3.03410Y3.489-0.455
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets663,893,733
Total Liabilities380,413,435
Total Stockholder Equity283,480,298
 As reported
Total Liabilities 380,413,435
Total Stockholder Equity+ 283,480,298
Total Assets = 663,893,733

Assets

Total Assets663,893,733
Total Current Assets392,739,486
Long-term Assets271,154,248
Total Current Assets
Total Current Assets  (as reported)392,739,486
Total Current Assets  (calculated)0
+/- 392,739,486
Long-term Assets
Long-term Assets  (as reported)271,154,248
Long-term Assets  (calculated)0
+/- 271,154,248

Liabilities & Shareholders' Equity

Total Current Liabilities292,670,205
Long-term Liabilities87,743,230
Total Stockholder Equity283,480,298
Total Current Liabilities
Total Current Liabilities  (as reported)292,670,205
Total Current Liabilities  (calculated)0
+/- 292,670,205
Long-term Liabilities
Long-term Liabilities  (as reported)87,743,230
Long-term Liabilities  (calculated)0
+/- 87,743,230
Total Stockholder Equity
Total Stockholder Equity (as reported)283,480,298
Total Stockholder Equity (calculated)0
+/- 283,480,298
Other
Common Stock Shares Outstanding 22,987
Net Invested Capital 283,480,298
Net Working Capital 100,069,281



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
631,419,520
600,606,944
602,762,829
589,368,538
612,530,881
607,981,552
613,938,250
594,119,511
630,160,454
611,778,343
625,047,525
617,459,285
616,715,916
610,511,551
635,762,700
651,774,906
633,048,889
630,310,800
638,138,411
630,873,131
660,787,997
621,201,810
618,880,666
593,791,187
608,520,370
601,228,622
582,903,533
573,207,865
570,949,528
575,857,069
560,486,026
549,085,029
534,233,097
583,696,723
591,310,281
633,053,136
635,851,582
624,268,769
623,985,744
627,972,755
671,086,327
647,763,434
667,183,190
645,038,796
657,445,021
663,893,733
663,893,733657,445,021645,038,796667,183,190647,763,434671,086,327627,972,755623,985,744624,268,769635,851,582633,053,136591,310,281583,696,723534,233,097549,085,029560,486,026575,857,069570,949,528573,207,865582,903,533601,228,622608,520,370593,791,187618,880,666621,201,810660,787,997630,873,131638,138,411630,310,800633,048,889651,774,906635,762,700610,511,551616,715,916617,459,285625,047,525611,778,343630,160,454594,119,511613,938,250607,981,552612,530,881589,368,538602,762,829600,606,944631,419,520
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
422,640,946
407,345,905
404,292,968
416,671,170
411,366,934
444,431,343
404,006,083
397,697,519
373,910,080
388,105,457
380,802,635
364,884,673
335,057,455
337,062,074
325,158,743
317,666,284
299,328,713
340,580,533
343,253,471
353,313,301
366,451,501
370,684,821
363,746,362
415,165,258
425,457,064
418,799,829
358,719,265
375,188,625
378,091,350
389,184,593
392,739,486
392,739,486389,184,593378,091,350375,188,625358,719,265418,799,829425,457,064415,165,258363,746,362370,684,821366,451,501353,313,301343,253,471340,580,533299,328,713317,666,284325,158,743337,062,074335,057,455364,884,673380,802,635388,105,457373,910,080397,697,519404,006,083444,431,343411,366,934416,671,170404,292,968407,345,905422,640,946000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,253,786
36,379,760
36,173,799
36,878,202
32,096,835
34,612,075
34,554,326
39,401,330
30,948,420
32,222,277
30,675,156
39,286,119
41,864,252
41,333,619
41,440,221
20,184,369
10,451,341
12,546,444
9,950,738
27,292,322
33,366,477
33,601,280
33,861,063
35,423,956
33,897,925
23,568,941
15,914,679
33,120,638
15,908,868
32,684,026
0
032,684,02615,908,86833,120,63815,914,67923,568,94133,897,92535,423,95633,861,06333,601,28033,366,47727,292,3229,950,73812,546,44410,451,34120,184,36941,440,22141,333,61941,864,25239,286,11930,675,15632,222,27730,948,42039,401,33034,554,32634,612,07532,096,83536,878,20236,173,79936,379,76039,253,786000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,000
35,000
50,000
60,000
0
600,000
0
0
0
0
8,251,996
12,499,442
0
0
0
22,574,818
44,839,817
51,493,138
46,874,845
41,897,267
32,299,584
35,824,832
35,853,709
111,134,661
115,780,803
112,192,624
45,730,068
47,194,861
78,287,564
76,083,885
0
076,083,88578,287,56447,194,86145,730,068112,192,624115,780,803111,134,66135,853,70935,824,83232,299,58441,897,26746,874,84551,493,13844,839,81722,574,81800012,499,4428,251,9960000600,000060,00050,00035,00020,000000000000000000
       Net Receivables 
274,073,749
252,715,389
260,979,989
240,795,039
251,192,671
255,898,370
266,198,658
266,715,699
302,525,119
282,200,399
290,092,766
283,213,042
285,941,963
285,557,371
283,782,036
282,024,527
261,231,518
259,855,672
271,411,516
268,166,528
290,255,073
248,628,744
236,274,550
229,696,892
235,825,156
224,566,598
197,495,741
182,772,958
165,318,035
155,638,723
148,122,462
128,129,015
158,085,661
167,219,457
162,970,545
187,378,945
184,237,273
176,272,050
153,108,990
156,361,517
141,947,207
173,061,031
160,480,130
159,377,671
154,800,942
0
0154,800,942159,377,671160,480,130173,061,031141,947,207156,361,517153,108,990176,272,050184,237,273187,378,945162,970,545167,219,457158,085,661128,129,015148,122,462155,638,723165,318,035182,772,958197,495,741224,566,598235,825,156229,696,892236,274,550248,628,744290,255,073268,166,528271,411,516259,855,672261,231,518282,024,527283,782,036285,557,371285,941,963283,213,042290,092,766282,200,399302,525,119266,715,699266,198,658255,898,370251,192,671240,795,039260,979,989252,715,389274,073,749
       Other Current Assets 
4,527,489
3,950,176
6,136,832
5,405,367
6,496,977
7,191,819
22,696,174
4,611,858
5,193,664
6,602,611
9,920,680
7,411,396
7,616,654
3,957,185
4,345,270
4,650,816
4,929,495
4,324,002
5,300,555
4,476,770
12,637,467
6,532,168
6,276,808
8,508,326
6,335,044
8,401,916
9,445,415
17,594,715
14,584,240
12,482,448
12,140,696
11,276,499
9,128,828
6,641,051
6,011,115
5,726,789
4,409,896
2,818,918
2,077,584
5,974,858
1,505,077
3,436,594
2,726,250
2,189,724
2,151,255
0
02,151,2552,189,7242,726,2503,436,5941,505,0775,974,8582,077,5842,818,9184,409,8965,726,7896,011,1156,641,0519,128,82811,276,49912,140,69612,482,44814,584,24017,594,7159,445,4158,401,9166,335,0448,508,3266,276,8086,532,16812,637,4674,476,7705,300,5554,324,0024,929,4954,650,8164,345,2703,957,1857,616,6547,411,3969,920,6806,602,6115,193,6644,611,85822,696,1747,191,8196,496,9775,405,3676,136,8323,950,1764,527,489
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
220,414,912
220,425,986
218,018,861
238,150,411
233,887,454
250,698,326
242,819,742
249,756,316
193,652,564
240,443,252
237,996,981
266,601,635
265,166,762
260,522,407
208,820,486
202,515,691
252,286,498
289,044,169
291,994,565
266,947,446
268,260,428
271,154,248
271,154,248268,260,428266,947,446291,994,565289,044,169252,286,498202,515,691208,820,486260,522,407265,166,762266,601,635237,996,981240,443,252193,652,564249,756,316242,819,742250,698,326233,887,454238,150,411218,018,861220,425,986220,414,912000000000000000000000000
       Property Plant Equipment 
149,699,919
148,504,555
146,175,173
144,078,626
142,141,292
141,227,985
139,284,885
136,287,386
133,687,998
132,060,659
131,815,614
129,725,372
127,970,321
126,421,311
125,737,901
126,961,224
125,171,331
123,177,945
121,585,137
122,119,532
120,139,752
119,556,574
118,577,781
117,770,229
118,174,956
118,419,505
118,097,944
150,429,742
148,812,859
152,840,377
150,769,334
185,571,718
118,681,577
119,489,478
118,684,482
118,392,269
115,920,252
118,258,756
117,907,074
123,048,115
158,757,163
154,814,703
155,385,460
155,723,670
157,795,102
0
0157,795,102155,723,670155,385,460154,814,703158,757,163123,048,115117,907,074118,258,756115,920,252118,392,269118,684,482119,489,478118,681,577185,571,718150,769,334152,840,377148,812,859150,429,742118,097,944118,419,505118,174,956117,770,229118,577,781119,556,574120,139,752122,119,532121,585,137123,177,945125,171,331126,961,224125,737,901126,421,311127,970,321129,725,372131,815,614132,060,659133,687,998136,287,386139,284,885141,227,985142,141,292144,078,626146,175,173148,504,555149,699,919
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,049,454
7,049,455
0
0
0
0
0
0
0
0
0
0
0
3,463,449
3,463,449
3,463,449
1,404,470
1,404,470
0
01,404,4701,404,4703,463,4493,463,4493,463,449000000000007,049,4557,049,454000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,386,478
3,436,912
3,884,671
3,937,055
3,943,347
3,985,929
4,080,778
8,969,529
8,905,014
9,015,513
8,855,332
8,780,405
5,232,288
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000005,232,2888,780,4058,855,3329,015,5138,905,0148,969,5294,080,7783,985,9293,943,3473,937,0553,884,6713,436,9123,386,478000000000000000
       Intangible Assets 
6,740,939
6,483,186
7,401,205
7,421,540
7,595,056
7,193,415
7,480,879
8,303,967
8,079,403
7,983,130
7,922,681
8,099,522
7,828,739
7,534,232
7,389,377
7,557,539
7,628,050
10,283,109
8,901,080
8,495,038
8,563,091
8,259,173
7,955,203
7,361,478
15,273,688
15,616,787
14,440,367
14,346,119
14,008,949
16,932,869
16,904,207
17,666,148
17,717,985
18,248,564
18,103,511
21,473,082
20,343,426
20,219,964
20,231,872
16,266,195
18,781,475
21,461,728
23,388,152
28,951,954
26,821,322
0
026,821,32228,951,95423,388,15221,461,72818,781,47516,266,19520,231,87220,219,96420,343,42621,473,08218,103,51118,248,56417,717,98517,666,14816,904,20716,932,86914,008,94914,346,11914,440,36715,616,78715,273,6887,361,4787,955,2038,259,1738,563,0918,495,0388,901,08010,283,1097,628,0507,557,5397,389,3777,534,2327,828,7398,099,5227,922,6817,983,1308,079,4038,303,9677,480,8797,193,4157,595,0567,421,5407,401,2056,483,1866,740,939
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,950,862
1
1,405,865
-1
-1
-1
0
0
0
0
0
-1
0
0
0
0
0
1
1
0
0
0
0001100000-100000-1-1-11,405,86511,950,862000000000000000000000000
> Total Liabilities 
458,376,397
421,482,456
412,763,480
388,629,268
392,153,097
392,542,848
396,057,861
370,291,943
400,389,613
382,445,476
394,687,110
388,074,345
388,873,029
398,914,114
360,253,463
374,764,691
360,933,648
358,940,448
361,912,851
360,096,626
388,191,023
336,863,593
331,641,518
333,680,091
355,452,228
346,654,611
327,140,393
343,116,046
351,405,916
364,288,447
345,282,851
341,618,154
329,826,369
383,277,566
385,314,260
444,513,607
445,279,462
432,251,984
422,871,650
402,213,719
437,385,404
385,118,716
422,647,883
379,598,339
382,187,944
380,413,435
380,413,435382,187,944379,598,339422,647,883385,118,716437,385,404402,213,719422,871,650432,251,984445,279,462444,513,607385,314,260383,277,566329,826,369341,618,154345,282,851364,288,447351,405,916343,116,046327,140,393346,654,611355,452,228333,680,091331,641,518336,863,593388,191,023360,096,626361,912,851358,940,448360,933,648374,764,691360,253,463398,914,114388,873,029388,074,345394,687,110382,445,476400,389,613370,291,943396,057,861392,542,848392,153,097388,629,268412,763,480421,482,456458,376,397
   > Total Current Liabilities 
353,614,470
318,721,119
317,778,306
316,279,507
285,766,881
242,244,334
244,939,557
211,435,444
257,601,905
273,951,439
286,973,271
260,781,279
292,558,932
318,726,652
232,516,508
257,975,368
251,519,291
248,157,055
255,938,293
274,537,164
289,639,969
250,231,809
238,987,973
228,368,447
297,801,983
289,267,493
260,073,268
277,983,375
266,715,413
270,948,234
261,646,194
234,747,629
246,171,806
247,598,808
247,746,198
282,677,564
253,281,878
239,104,215
340,850,777
380,131,098
387,656,876
316,274,987
324,113,141
286,927,114
295,489,324
292,670,205
292,670,205295,489,324286,927,114324,113,141316,274,987387,656,876380,131,098340,850,777239,104,215253,281,878282,677,564247,746,198247,598,808246,171,806234,747,629261,646,194270,948,234266,715,413277,983,375260,073,268289,267,493297,801,983228,368,447238,987,973250,231,809289,639,969274,537,164255,938,293248,157,055251,519,291257,975,368232,516,508318,726,652292,558,932260,781,279286,973,271273,951,439257,601,905211,435,444244,939,557242,244,334285,766,881316,279,507317,778,306318,721,119353,614,470
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
251,172,428
246,410,002
252,019,424
16,000,000
45,978,929
35,992,085
35,995,561
35,999,098
16,000,000
177,377,315
172,964,628
164,659,686
154,952,458
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000154,952,458164,659,686172,964,628177,377,31516,000,00035,999,09835,995,56135,992,08545,978,92916,000,000252,019,424246,410,002251,172,428000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
251,172,428
246,410,002
252,019,424
16,000,000
45,978,929
35,992,085
35,995,561
35,999,098
16,000,000
177,377,315
172,964,628
164,659,686
154,952,458
137,310,000
150,024,617
115,357,476
106,466,176
110,066,032
115,175,983
110,633,427
121,800,182
99,738,114
88,950,041
178,449,493
206,439,729
248,334,656
165,696,311
123,751,267
113,134,174
94,166,320
0
094,166,320113,134,174123,751,267165,696,311248,334,656206,439,729178,449,49388,950,04199,738,114121,800,182110,633,427115,175,983110,066,032106,466,176115,357,476150,024,617137,310,000154,952,458164,659,686172,964,628177,377,31516,000,00035,999,09835,995,56135,992,08545,978,92916,000,000252,019,424246,410,002251,172,428000000000000000
       Accounts payable 
43,661,053
44,629,740
33,192,083
32,167,597
34,626,241
27,270,131
27,592,944
33,750,550
33,141,774
36,812,198
34,621,627
36,185,429
35,886,033
42,926,432
44,680,521
59,395,280
50,249,226
43,893,827
59,551,074
59,586,118
56,691,138
47,970,960
58,443,969
44,464,608
58,405,619
0
0
45,087,219
52,532,494
49,616,432
69,024,874
47,885,391
48,089,142
47,940,969
51,002,570
51,642,851
54,358,618
58,613,559
55,471,305
82,907,880
59,602,165
57,212,187
72,290,147
73,847,213
81,570,606
0
081,570,60673,847,21372,290,14757,212,18759,602,16582,907,88055,471,30558,613,55954,358,61851,642,85151,002,57047,940,96948,089,14247,885,39169,024,87449,616,43252,532,49445,087,2190058,405,61944,464,60858,443,96947,970,96056,691,13859,586,11859,551,07443,893,82750,249,22659,395,28044,680,52142,926,43235,886,03336,185,42934,621,62736,812,19833,141,77433,750,55027,592,94427,270,13134,626,24132,167,59733,192,08344,629,74043,661,053
       Other Current Liabilities 
25,339,034
25,149,432
23,835,323
22,836,141
21,702,919
24,199,529
36,188,204
32,675,377
31,931,792
28,859,726
30,720,257
34,637,283
33,030,353
49,012,408
33,960,993
35,577,550
34,332,780
32,264,626
38,100,815
38,093,749
51,955,126
41,654,059
49,050,796
51,124,763
19,900,563
24,735,477
25,610,474
72,085,710
71,210,850
63,652,691
70,263,158
74,554,732
81,495,481
75,584,642
78,504,013
97,617,010
87,870,926
79,272,869
92,613,252
77,058,262
22,898,088
76,970,328
23,840,033
12,899,977
13,010,266
0
013,010,26612,899,97723,840,03376,970,32822,898,08877,058,26292,613,25279,272,86987,870,92697,617,01078,504,01375,584,64281,495,48174,554,73270,263,15863,652,69171,210,85072,085,71025,610,47424,735,47719,900,56351,124,76349,050,79641,654,05951,955,12638,093,74938,100,81532,264,62634,332,78035,577,55033,960,99349,012,40833,030,35334,637,28330,720,25728,859,72631,931,79232,675,37736,188,20424,199,52921,702,91922,836,14123,835,32325,149,43225,339,034
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
57,650,245
57,387,118
67,067,125
65,132,671
84,690,503
93,340,213
83,636,657
106,870,525
83,654,563
135,678,759
137,568,062
161,836,043
191,997,584
193,147,769
82,020,872
22,082,621
49,728,527
68,843,729
98,534,741
92,671,226
86,698,620
87,743,230
87,743,23086,698,62092,671,22698,534,74168,843,72949,728,52722,082,62182,020,872193,147,769191,997,584161,836,043137,568,062135,678,75983,654,563106,870,52583,636,65793,340,21384,690,50365,132,67167,067,12557,387,11857,650,245000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-251,172,428
-246,410,002
-252,019,424
-16,000,000
-45,978,929
-35,992,085
-35,995,561
-35,999,098
-16,000,000
-175,170,600
-169,187,206
-161,480,780
-152,560,593
1,885,569
2,439,411
2,749,441
2,169,034
1,851,811
3,672,721
3,018,234
2,600,867
2,048,146
3,514,719
2,927,891
3,102,585
33,095,783
28,442,696
27,786,992
27,146,266
26,786,473
0
026,786,47327,146,26627,786,99228,442,69633,095,7833,102,5852,927,8913,514,7192,048,1462,600,8673,018,2343,672,7211,851,8112,169,0342,749,4412,439,4111,885,569-152,560,593-161,480,780-169,187,206-175,170,600-16,000,000-35,999,098-35,995,561-35,992,085-45,978,929-16,000,000-252,019,424-246,410,002-251,172,428000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
1
0
0
1
0
-1
0
0
0
0
-1
0
1
-1
0
1,316,566
0
0
001,316,5660-110-10000-101001-1000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,833,492
14,735,857
13,750,248
12,736,292
11,641,677
10,746,974
9,787,396
8,689,943
7,775,649
7,289,655
7,476,103
6,633,152
5,939,668
5,622,810
5,166,238
5,119,747
5,357,890
5,684,534
6,397,261
6,506,843
8,699,955
8,646,807
8,575,518
8,452,995
4,515,969
0
9,801,365
0
0
0
0
00009,801,36504,515,9698,452,9958,575,5188,646,8078,699,9556,506,8436,397,2615,684,5345,357,8905,119,7475,166,2385,622,8105,939,6686,633,1527,476,1037,289,6557,775,6498,689,9439,787,39610,746,97411,641,67712,736,29213,750,24814,735,85715,833,492000000000000000
> Total Stockholder Equity
173,043,123
179,124,488
189,999,349
200,739,269
220,377,784
215,438,704
217,880,389
223,827,568
229,770,842
229,332,868
230,360,414
229,384,940
227,842,887
211,597,437
275,509,237
277,010,215
272,115,241
271,370,353
276,225,560
270,776,505
272,596,974
281,053,857
283,954,788
256,826,736
253,068,142
254,574,011
255,763,140
230,081,681
219,535,201
211,559,165
215,189,308
207,490,914
204,387,019
200,826,946
206,470,583
201,194,767
203,365,635
204,941,365
214,189,624
240,354,100
248,416,633
262,644,716
244,535,306
265,440,456
275,257,075
283,480,298
283,480,298275,257,075265,440,456244,535,306262,644,716248,416,633240,354,100214,189,624204,941,365203,365,635201,194,767206,470,583200,826,946204,387,019207,490,914215,189,308211,559,165219,535,201230,081,681255,763,140254,574,011253,068,142256,826,736283,954,788281,053,857272,596,974270,776,505276,225,560271,370,353272,115,241277,010,215275,509,237211,597,437227,842,887229,384,940230,360,414229,332,868229,770,842223,827,568217,880,389215,438,704220,377,784200,739,269189,999,349179,124,488173,043,123
   Common Stock
31,743,275
32,665,328
34,492,048
34,492,048
36,233,510
36,324,818
36,690,048
37,657,905
41,131,563
44,627,330
44,627,330
44,627,330
46,856,690
46,856,690
46,856,690
46,856,690
47,792,780
47,792,780
47,792,780
47,878,093
49,092,963
49,272,585
49,503,240
49,513,650
50,795,055
50,795,055
50,795,055
54,091,805
55,615,810
55,615,810
55,615,810
55,615,810
57,184,938
57,184,938
57,184,938
57,202,368
58,818,195
58,818,195
58,818,195
59,418,178
0
61,099,530
0
0
0
0
000061,099,530059,418,17858,818,19558,818,19558,818,19557,202,36857,184,93857,184,93857,184,93855,615,81055,615,81055,615,81055,615,81054,091,80550,795,05550,795,05550,795,05549,513,65049,503,24049,272,58549,092,96347,878,09347,792,78047,792,78047,792,78046,856,69046,856,69046,856,69046,856,69044,627,33044,627,33044,627,33041,131,56337,657,90536,690,04836,324,81836,233,51034,492,04834,492,04832,665,32831,743,275
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000-4,238,002-808,291-808,291-517,269-517,269-517,269-807,188-489,902-489,902-489,902-489,902-271,266-271,266-271,266-271,266-233,610-233,610-233,610-233,610-190,855-190,855-190,855-190,855
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43,392,686
43,296,694
43,323,183
43,329,742
43,244,397
43,244,615
43,313,311
43,295,935
33,277,966
33,328,315
33,358,413
33,404,831
33,300,756
32,672,180
33,199,894
33,878,626
32,639,833
33,065,531
32,869,221
33,422,393
32,846,621
33,067,030
33,660,528
34,617,818
31,807,772
0
33,127,255
0
0
0
0
000033,127,255031,807,77234,617,81833,660,52833,067,03032,846,62133,422,39332,869,22133,065,53132,639,83333,878,62633,199,89432,672,18033,300,75633,404,83133,358,41333,328,31533,277,96643,295,93543,313,31143,244,61543,244,39743,329,74243,323,18343,296,69443,392,686000000000000000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue748,526,708
Cost of Revenue-412,984,312
Gross Profit335,542,396335,542,396
 
Operating Income (+$)
Gross Profit335,542,396
Operating Expense-647,610,069
Operating Income100,916,639-312,067,673
 
Operating Expense (+$)
Research Development33,671,364
Selling General Administrative152,639,104
Selling And Marketing Expenses0
Operating Expense647,610,069186,310,468
 
Net Interest Income (+$)
Interest Income5,893,147
Interest Expense-12,561,689
Other Finance Cost-1,395,774
Net Interest Income-5,272,768
 
Pretax Income (+$)
Operating Income100,916,639
Net Interest Income-5,272,768
Other Non-Operating Income Expenses0
Income Before Tax (EBT)54,836,450100,916,639
EBIT - interestExpense = -12,561,689
37,006,334
49,568,023
Interest Expense12,561,689
Earnings Before Interest and Taxes (EBIT)067,398,139
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax54,836,450
Tax Provision-16,406,190
Net Income From Continuing Ops38,430,26038,430,260
Net Income37,006,334
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net05,272,768
 

Technical Analysis of Jw Pharmac
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jw Pharmac. The general trend of Jw Pharmac is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jw Pharmac's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jw Pharmac.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 27,000 < 30,400 < 30,900.

The bearish price targets are: 25,400 > 25,000 > 24,950.

Tweet this
Jw Pharmac Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jw Pharmac. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jw Pharmac Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jw Pharmac. The current macd is -435.43201855.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Jw Pharmac price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Jw Pharmac. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Jw Pharmac price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Jw Pharmac Daily Moving Average Convergence/Divergence (MACD) ChartJw Pharmac Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jw Pharmac. The current adx is 17.22.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Jw Pharmac shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Jw Pharmac Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jw Pharmac. The current sar is 30,612.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Jw Pharmac Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jw Pharmac. The current rsi is 42.39. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Jw Pharmac Daily Relative Strength Index (RSI) ChartJw Pharmac Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jw Pharmac. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jw Pharmac price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Jw Pharmac Daily Stochastic Oscillator ChartJw Pharmac Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jw Pharmac. The current cci is -70.72103202.

Jw Pharmac Daily Commodity Channel Index (CCI) ChartJw Pharmac Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jw Pharmac. The current cmo is -18.45222546.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Jw Pharmac Daily Chande Momentum Oscillator (CMO) ChartJw Pharmac Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jw Pharmac. The current willr is -68.68686869.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Jw Pharmac is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Jw Pharmac Daily Williams %R ChartJw Pharmac Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jw Pharmac.

Jw Pharmac Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jw Pharmac. The current atr is 993.54.

Jw Pharmac Daily Average True Range (ATR) ChartJw Pharmac Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jw Pharmac. The current obv is 15,447,816.

Jw Pharmac Daily On-Balance Volume (OBV) ChartJw Pharmac Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jw Pharmac. The current mfi is 38.37.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Jw Pharmac Daily Money Flow Index (MFI) ChartJw Pharmac Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jw Pharmac.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-06-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-07-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Jw Pharmac Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jw Pharmac based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.388
Ma 20Greater thanMa 5027,995.000
Ma 50Greater thanMa 10028,139.000
Ma 100Greater thanMa 20029,320.000
OpenGreater thanClose27,000.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Jw Pharmac with someone you think should read this too:
  • Are you bullish or bearish on Jw Pharmac? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jw Pharmac? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jw Pharmac

I send you an email if I find something interesting about Jw Pharmac.


Comments

How you think about this?

Leave a comment

Stay informed about Jw Pharmac.

Receive notifications about Jw Pharmac in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.